A Hidden Crisis: The Need for Treatments in Notalgia Paresth

A silent disease characterized as a chronic cutaneous neuropathy, notalgia paresthetica has an unmet need yet to be fully understood and, dermatologists argue, an FDA-approved treatment could help improve understanding of the etiology and prevalence of this disease.

Related Keywords

Russia , Massachusetts , United States , Russian , Chris Bunick , Pamela Weinfeld , Raj Chovatiya , Brian Kim , Caridad Gomez , Mount Sinai Health System , Yale School Of Medicine , Icahn School Of Medicine At Mount Sinai , Drug Administration , Ericj Waldman Department Of Dermatology , Northwestern University , Skin Care Associates , Research For The Kimberly , Yale School , New England Journal , Icahn School , Worst Itch Numeric Rating Scale , Paresthetica Review , Notalgia Paresthetica With Botulinum Toxin Type , England Journal , Sinai Health , Published February , Published August ,